Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exiqon Introduces microRNA qPCR Panels for Stem Cell Research

Published: Wednesday, April 18, 2012
Last Updated: Wednesday, April 18, 2012
Bookmark and Share
Scientists to apply a panel of qPCR microRNA assays optimized for embryonic and induced pluripotent research.

Exiqon A/S has launched microRNA qPCR panels for stem cell research.
The new Stem Cell Focus microRNA PCR Panels allow scientists interested in stem cell research to apply a panel of qPCR microRNA assays optimized for embryonic and induced pluripotent research.

The 85 qPCR and 11 control assays have been experimentally optimized and validated to fit the needs of researchers interested in differentiation, proliferation, development and homeostasis of stem cells.

Recent research has documented the importance of microRNAs in the differentiation of stem cells as microRNAs are directly involved in determining the fate of the undifferentiated stem cells and in the process of inducing pluripotency of differentiated cells.

The Stem Cell Focus microRNA PCR Panels offered by Exiqon are perfectly suited for testing the degree and type of differentiation as well as the quality of the differentiation.

In a comment, Senior Vice President Sales & Marketing Henrik M. Pfundheller said: “We understand from our customers that they only have access to very limited sample material. We are therefore offering a product that only requires a 10 µl reaction volume and can detect down to 5 copies of microRNAs which is unprecedented in the market”.

He added: “Also microRNAs with high sequence content of A and T that are normally hard to detect are readily detected due to the inclusion of LNA™ in the PCR primers”.

The Stem Cell Focus microRNA PCR Panels are based on the most sensitive microRNA qPCR platform available with required sample input of as little as 1 pg of total RNA without any need for pre-amplification and thus avoiding risk of introducing bias in the generation of cDNA due to the unique universal RT step.

All major brands of qPCR instruments are supported by the Stem Cell Focus microRNA PCR Panels including instruments for both 96 and 384 well array formats.

The Stem Cell Focus microRNA PCR Panels are fully compatible with all other products in the miRCURY LNA™ Universal RT microRNA PCR system product line including the data analysis software. The entire work process from sample to data can be completed in 3 hours.

Exiqon offers a complete range of PCR products for the microRNA analysis which includes ready-to-use panels for genome-wide screening of human, mouse and rat microRNAs, numerous other focus panels, the fully flexible Pick & Mix panels, spike in kits, as well as RT and Master Mix kits, sample preparation and a unique qPCR data analysis software.

If customers have identified proprietary microRNAs and would like to take advantage of Exiqon’s proprietary LNA™ chemistry and unique RT technology, Exiqon also offers an easy to use design software for high quality design of custom microRNA qPCR assays.

The miRCURY LNA™ microRNA PCR is also accessible via Exiqon Services.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Exiqon Announces 2012 Grant Program for MicroRNA Research
The company announced the launch of its 2012 global research grant program, open to researchers from academic and non-profit institutions.
Thursday, January 05, 2012
Exiqon and Roswell Park Sign Center of Excellence Agreement
Roswell Park to provide real-time PCR services based on Exiqon’s miRCURY LNA™ Universal RT microRNA PCR product line.
Friday, October 07, 2011
Exiqon to Present New Data at AACR Conference
Data from company’s diagnostic program on early detection of colorectal cancer in plasma has been selected for oral presentation at the 102nd AACR.
Monday, April 11, 2011
Scientific News
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Quick, Early Test For Ebola Could Prevent Epidemics
Researchers from Princeton University are collaborating with U.S. government labs to develop a more rapid, accurate and inexpensive test for the Ebola virus with the aim of identifying infections before carriers become symptomatic and contagious.
From Super to Ultra-Resolution Microscopy
A new method pushes the frontier in imaging resolution, with the potential to distinguish individual features in single molecules.
Cancer Research UK joins forces with U.S. 'Cancer Moonshot'
Cancer Research UK and the US government’s National Cancer Institute have announced that two teams will work together to radically accelerate progress against cancer, in one of the first international collaborations inspired by US Vice President Joe Biden’s Cancer Moonshot.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
Measuring the Abundance of Extremely Rare Mutations
Researchers from Rutgers University demonstrate the use of multiplex real-time PCR assays to measure the abundance of extremely rare mutations associated with cancer.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!